Literature DB >> 9688299

Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.

X Shao1, R Tandon, G Samara, H Kanki, H Yano, L G Close, R Parsons, T Sato.   

Abstract

Loss of heterozygosity (LOH) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carcinoma of the head and neck (SCCHN), DNAs from both normal muscle and tumor tissue in 19 SCCHN were used for detecting LOH at chromosome 10q23 and mutational analysis of PTEN by direct polymerase chain reaction (PCR)-DNA sequencing. LOH at 10q23 was identified in 6/15 SCCHN. Mutation of PTEN was identified in 3/19 SCCHN. Of these 3 patients, 2 had stage IV disease; the third patient, with recurrent, metastatic and stage III disease, showed a 36 bp germline heterozygous deletion within intron 7. Furthermore, a missense mutation at codon 501 (TCT --> TTT: Ser --> Phe) in exon 8 was also found in tumor from the same patient. Our results suggest that PTEN may play a role in the genesis of some SCCHNs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688299     DOI: 10.1002/(sici)1097-0215(19980831)77:5<684::aid-ijc4>3.0.co;2-r

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.

Authors:  Chao-Nan Qian; Kyle A Furge; Jared Knol; Dan Huang; Jindong Chen; Karl J Dykema; Eric J Kort; Aaron Massie; Sok Kean Khoo; Kristin Vanden Beldt; James H Resau; John Anema; Richard J Kahnoski; Hans Morreau; Philippe Camparo; Eva Comperat; Mathilde Sibony; Yves Denoux; Vincent Molinie; Annick Vieillefond; Charis Eng; Bart O Williams; Bin Tean Teh
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

2.  PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.

Authors:  Nnamdi Eze; Ju-Whei Lee; Dong-Hua Yang; Fang Zhu; Veronique Neumeister; Teresa Sandoval-Schaefer; Ranee Mehra; John A Ridge; Arlene Forastiere; Christine H Chung; Barbara Burtness
Journal:  Oral Oncol       Date:  2019-03-04       Impact factor: 5.337

3.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

4.  PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients.

Authors:  Nisreen Sherif Alyasiri; Syed Jafar Mehdi; M Shabbir Alam; Asgar Ali; Ashish K Mandal; Sunita Gupta; Ishwar Singh; M Moshahid Alam Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-28       Impact factor: 4.553

5.  Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

Authors:  Y Bian; B Hall; Z-J Sun; A Molinolo; W Chen; J S Gutkind; C V Waes; A B Kulkarni
Journal:  Oncogene       Date:  2011-10-31       Impact factor: 9.867

6.  Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.

Authors:  Punnya V Angadi; Rekha Krishnapillai
Journal:  Head Neck Pathol       Date:  2012-03-06

7.  RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).

Authors:  Kathrin Scheckenbach; Stephan E Baldus; Vera Balz; Marcel Freund; Petra Pakropa; Christoph Sproll; Karl-Ludwig Schäfer; Martin Wagenmann; Jörg Schipper; Helmut Hanenberg
Journal:  Oral Oncol       Date:  2013-12-06       Impact factor: 5.337

8.  Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.

Authors:  Vivian W Y Lui; Matthew L Hedberg; Hua Li; Bhavana S Vangara; Kelsey Pendleton; Yan Zeng; Yiling Lu; Qiuhong Zhang; Yu Du; Breean R Gilbert; Maria Freilino; Sam Sauerwein; Noah D Peyser; Dong Xiao; Brenda Diergaarde; Lin Wang; Simion Chiosea; Raja Seethala; Jonas T Johnson; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris; Marjorie Romkes; Tomoko Nukui; Patrick Kwok-Shing Ng; Levi A Garraway; Peter S Hammerman; Gordon B Mills; Jennifer R Grandis
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

Review 9.  The molecular pathogenesis of head and neck squamous cell carcinoma.

Authors:  S Michael Rothenberg; Leif W Ellisen
Journal:  J Clin Invest       Date:  2012-06       Impact factor: 14.808

10.  Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.

Authors:  Ann Marie Egloff; Jennifer Rubin Grandis
Journal:  J Oncol       Date:  2009-07-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.